An australian audit of vaccination status in children and adolescents with inflammatory bowel disease
More >> Seven million Syrians, or nearly one-third of the population, have been displaced by the country’s civil war, but international aid to them has been a “drop in the sea” of humanitarian need, a top UN official said Monday. More >> Iran releases 6 Slovaks; 2 more still held Iran says it has freed six Slovak nationals who spent more than two months in jail for breaking unspecified laws, but two others remain in detention. More >> Iran says it has freed six Slovak nationals who spent more than two months in jail for breaking unspecified laws, but two others remain in detention. More >> (Seven Network/CNN) – Australian opposition leader Tony Abbott set social media abuzz Monday with a memorable slip of the tongue. “No one – however smart, however well-educated, however experienced – is the suppository of all wisdom,” Abbott told a Liberal Party event in the city of Melbourne. A suppository is “a small piece of medicated substance, usually conical, ovoid, or cylindrical, introduced into a body passage, as the rectum or vagina, where body heat causes it to melt,” according to Webster’s New World College Dictionary. It’s not quite the same as a repository (a place in which things may be placed for safekeeping), the word typically used in the expression “the repository of all wisdom.” Abbott’s unwitting switch of the two words both shocked and amused his audience. “There was an audible gasp in the room, a few people snickering,” said Jonathan Swan, a political reporter for Fairfax Media who was at the event. As news of Abbott’s unfortunate utterance filtered out, social media users quickly seized on the gaffe. The hashtag #suppository began trending on Twitter in Australia. And people couldn’t resist exploiting the situation’s comic and crude potential. “Oh dear. Abbott we are not the ‘suppository” of all wisdom.’ Not sure where to stick this one,” wrote Marcus Priest, a political reporter for the Australian Financial Review. It’s not the kind of coverage Abbott’s aides will have been hoping for ahead of national elections next month.
Table 2. Baseline Characteristics One hundred and one hospital patient records were reviewed as detailed in the study flow diagram. (Figure 1 ) A telephone immunization survey was completed in 42% and primary care practitioner records obtained in 66% (33/50) of consenting participants. In those whom a complete telephone immunization survey was obtained, 90% (38/42) [95% confidence intervals (CI) 77%; 97%] were up-to date with routine primary childhood immunizations. Figure 1. Flow diagram of study participants. For additional recommended vaccines, only 5% (5/101) [95% CI 2%; 11%] had received a recommended pneumococcal ‘booster’ and all were on active therapy including azathioprine (4) and infliximab (1). 10% (10/101) [95% CI 5%; 17%] had evidence of having ever received an influenza vaccination, 7% (7/101) [95% CI 3%; 14%] in the year of the survey. Those living in rural Victoria (Odds ratio 6.51 95% CI 1.33; 41.25, p = 0.005) and younger at the age of diagnosis (Pearson square for trend 2 = 16.8; p = 0.002) were more likely to have received an influenza vaccine. The reasons for not having received an influenza vaccine (n = 33) included: not being aware of it (24%); concerned about side effects (24%) not necessary (15%); doctor did not offer it (6%), allergy (6%) and unspecified or other reason (25%). Serological testing, reviewing historical protection from VPD, identified 18% (17/94) with evidence of at least one serology sample. Having serology testing was not associated with age (2 for trend = 1.7; p = 0.42). For the patients who had varicella serology, 18% (2/11) were negative. Pre-diagnosis varicella vaccine had been received by 8 participants, with an additional 30 confirming pre-diagnosis clinical infection. There were four participants (none currently on infliximab) who had hepatitis B serology documented, all were negative for hepatitis B surface antigen (HepBsAg) and seropositive for protective anti-HepB surface antibody. On Hepatitis B vaccination history, immunization was confirmed in 93% (39/42), including 86% (6/7) of those currently on infliximab.
visit this page http://www.biomedcentral.com/1471-230X/11/87